Key facts
- IngredientAI’s last known valuation is $29.0M (Jan 2025).
- It has raised $6.9M; the latest was Seed Round ($6.9M) in Jan 2025.
- Notable investors include Maverick Ventures, Tola Capital.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for IngredientAI
- ·The full record, as it builds
Funding rounds
No funding rounds for IngredientAI are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About IngredientAI
Developer of an AI-powered platform designed for the nutraceutical industry to streamline the supplement formulation process. The company's platform uses artificial intelligence to provide pricing estimates, generative AI research and recommendations, and summaries linked to relevant research to accelerate innovation, enabling supplement brands to align, analyze, and drive innovations-all with the research right at hand.
- Sector
- Information Technology
- HQ
- New York, NY, United States
- Founded
- 2023
- Employees
- 9
- Website
- ingredient-ai.com/
- Ownership
- Privately Held (backing)
IngredientAI doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in IngredientAI shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on IngredientAI in its N-PORT filings yet. We sweep new filings monthly.